Group 1 - The core viewpoint of the news is that Yipinhong Pharmaceutical Group Co., Ltd. has shown a significant stock price increase of 5.23%, reaching 70.19 CNY per share, with a total market capitalization of 31.704 billion CNY [1] - Yipinhong's main business includes the research, production, and sales of its own pharmaceuticals, as well as the sales of agent pharmaceuticals, with revenue composition being 61.12% from children's medicine, 22.71% from chronic disease medicine, and 16.17% from other products [1] Group 2 - According to fund data, Nord Fund has a significant holding in Yipinhong, with the Nord Small and Mid-Cap Mixed Fund (570006) holding 27,000 shares, accounting for 4.49% of the fund's net value, ranking as the tenth largest holding [2] - The Nord Small and Mid-Cap Mixed Fund has achieved a year-to-date return of 52.57%, ranking 541 out of 8248 in its category, and a one-year return of 53.23%, ranking 2182 out of 8051 [2] Group 3 - The fund manager of the Nord Small and Mid-Cap Mixed Fund is Zhu Mingrui, who has been in the position for 3 years and 68 days, with the fund's total asset size being 70.9838 million CNY [3] - During Zhu Mingrui's tenure, the best fund return was 43.58%, while the worst return was -6.35% [3]